The effects of resveratrol supplementation in patients with type 2 diabetes, metabolic syndrome, and nonalcoholic fatty liver disease: an umbrella review of meta-analyses of randomized controlled trials
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The effects of resveratrol supplementation in patients with type 2 diabetes, metabolic syndrome, and nonalcoholic fatty liver disease: an umbrella review of meta-analyses of randomized controlled trials
Authors
Keywords
-
Journal
AMERICAN JOURNAL OF CLINICAL NUTRITION
Volume -, Issue -, Pages -
Publisher
Oxford University Press (OUP)
Online
2021-07-09
DOI
10.1093/ajcn/nqab250
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The effect of resveratrol supplementation on C-reactive protein (CRP) in type 2 diabetic patients: Results from a systematic review and meta-analysis of randomized controlled trials
- (2020) Hossein Hosseini et al. COMPLEMENTARY THERAPIES IN MEDICINE
- The effects of resveratrol on lipid profiles and liver enzymes in patients with metabolic syndrome and related disorders: a systematic review and meta-analysis of randomized controlled trials
- (2020) Maryam Akbari et al. Lipids in Health and Disease
- Fine wine or sour grapes? A systematic review and meta-analysis of the impact of red wine polyphenols on vascular health
- (2020) Samuel R. Weaver et al. EUROPEAN JOURNAL OF NUTRITION
- Mechanisms, screening modalities and treatment options for individuals with non‐alcoholic fatty liver disease and type 2 diabetes
- (2020) T. J. Hydes et al. DIABETIC MEDICINE
- Effects of Resveratrol Supplementation in Patients with Non-Alcoholic Fatty Liver Disease—A Meta-Analysis
- (2020) Karolina Jakubczyk et al. Nutrients
- The Circadian Syndrome: is the metabolic syndrome and much more!
- (2019) P Zimmet et al. JOURNAL OF INTERNAL MEDICINE
- Effect of resveratrol on metabolic syndrome components: A systematic review and meta-analysis
- (2019) Sedigheh Asgary et al. REVIEWS IN ENDOCRINE & METABOLIC DISORDERS
- Role of diet in type 2 diabetes incidence: umbrella review of meta-analyses of prospective observational studies
- (2019) Manuela Neuenschwander et al. BMJ-British Medical Journal
- Effects of resveratrol supplementation on bone biomarkers: a systematic review and meta‐analysis
- (2019) Marzieh Asis et al. Annals of the New York Academy of Sciences
- WITHDRAWN: Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the International Diabetes Federation Diabetes Atlas, 9th edition
- (2019) Pouya Saeedi et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- The Effect of Resveratrol Supplementation on Cardio‐Metabolic Risk Factors in Patients with Type 2 Diabetes: A Randomized, Double‐Blind Controlled Trial
- (2019) Shima Abdollahi et al. PHYTOTHERAPY RESEARCH
- Resveratrol supplementation improves metabolic control in rats with induced hyperlipidemia and type 2 diabetes
- (2019) Aleksandar Rašković et al. SAUDI PHARMACEUTICAL JOURNAL
- Therapeutic effect of resveratrol supplementation on oxidative stress: a systematic review and meta-analysis of randomised controlled trials
- (2019) Mehdi Koushki et al. POSTGRADUATE MEDICAL JOURNAL
- Evidence-based nutritional and pharmacological interventions targeting chronic low-grade inflammation in middle-age and older adults: A systematic review and meta-analysis
- (2018) C. Custodero et al. AGEING RESEARCH REVIEWS
- Effect of resveratrol on blood pressure: A systematic review and meta-analysis of randomized, controlled, clinical trials
- (2018) Federica Fogacci et al. CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION
- Resveratrol reduces albuminuria in diabetic nephropathy: A randomized double-blind placebo-controlled clinical trial
- (2018) A. Sattarinezhad et al. DIABETES & METABOLISM
- Can resveratrol supplement change inflammatory mediators? A systematic review and meta-analysis on randomized clinical trials
- (2018) Fahimeh Haghighatdoost et al. EUROPEAN JOURNAL OF CLINICAL NUTRITION
- Resveratrol regulates blood pressure by enhancing AMPK signaling to downregulate a Rac1-derived NADPH oxidase in the central nervous system
- (2018) Tung-Chen Yeh et al. JOURNAL OF APPLIED PHYSIOLOGY
- Effect of resveratrol supplementation on cognitive performance and mood in adults: a systematic literature review and meta-analysis of randomized controlled trials
- (2018) Wolfgang Marx et al. NUTRITION REVIEWS
- Role of Oxidative Stress in Pathophysiology of Nonalcoholic Fatty Liver Disease
- (2018) Mario Masarone et al. Oxidative Medicine and Cellular Longevity
- Effect of resveratrol on lipid profile: An updated systematic review and meta-analysis on randomized clinical trials
- (2018) Fahimeh Haghighatdoost et al. PHARMACOLOGICAL RESEARCH
- The effects of resveratrol intake on weight loss: a systematic review and meta-analysis of randomized controlled trials
- (2018) Reza Tabrizi et al. CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION
- Effect of Resveratrol on Blood Lipid Levels in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis
- (2018) Hang Zhao et al. Obesity
- Resveratrol supplementation significantly influences obesity measures: a systematic review and dose-response meta-analysis of randomized controlled trials
- (2018) S. M. Mousavi et al. Obesity Reviews
- Effects of resveratrol on glucose control and insulin sensitivity in subjects with type 2 diabetes: systematic review and meta-analysis
- (2017) Xiangyun Zhu et al. Nutrition & Metabolism
- Resveratrol supplementation and plasma adipokines concentrations? A systematic review and meta-analysis of randomized controlled trials
- (2017) Mohsen Mohammadi-Sartang et al. PHARMACOLOGICAL RESEARCH
- AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both
- (2017) Beverley J Shea et al. BMJ-British Medical Journal
- AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both
- (2017) Beverley J Shea et al. BMJ-British Medical Journal
- Resveratrol lowers blood pressure in spontaneously hypertensive rats via calcium-dependent endothelial NO production
- (2016) Xin Li et al. CLINICAL AND EXPERIMENTAL HYPERTENSION
- Six months of resveratrol supplementation has no measurable effect in type 2 diabetic patients. A randomized, double blind, placebo-controlled trial
- (2016) S. Bo et al. PHARMACOLOGICAL RESEARCH
- Placebo-controlled, randomised clinical trial: high-dose resveratrol treatment for non-alcoholic fatty liver disease
- (2016) Sara Heebøll et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Resveratrol and diabetes: from animal to human studies
- (2015) Tomasz Szkudelski et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Effect of resveratrol on blood pressure: A meta-analysis of randomized controlled trials
- (2015) Yanxia Liu et al. CLINICAL NUTRITION
- Resveratrol improves insulin resistance, glucose and lipid metabolism in patients with non-alcoholic fatty liver disease: A randomized controlled trial
- (2015) Shihui Chen et al. DIGESTIVE AND LIVER DISEASE
- Lack of efficacy of resveratrol on C-reactive protein and selected cardiovascular risk factors — Results from a systematic review and meta-analysis of randomized controlled trials
- (2015) Amirhossein Sahebkar et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Effect of resveratrol on glucose control and insulin sensitivity: a meta-analysis of 11 randomized controlled trials
- (2014) Kai Liu et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- Effect of Resveratrol on Serum and Liver Lipid Profile and Antioxidant Activity in Hyperlipidemia Rats
- (2014) Lixian Zhu et al. ASIAN-AUSTRALASIAN JOURNAL OF ANIMAL SCIENCES
- Resveratrol Does Not Benefit Patients With Nonalcoholic Fatty Liver Disease
- (2014) Veronique S. Chachay et al. Clinical Gastroenterology and Hepatology
- Insulin Resistance, Diabetes, and Cardiovascular Risk
- (2014) Francesco Paneni et al. Current Atherosclerosis Reports
- Effects of Resveratrol in Patients with Type 2 Diabetes Mellitus on Skeletal Muscle SIRT1 Expression and Energy Expenditure
- (2014) Kian Peng Goh et al. INTERNATIONAL JOURNAL OF SPORT NUTRITION AND EXERCISE METABOLISM
- Resveratrol Increases Bone Mineral Density and Bone Alkaline Phosphatase in Obese Men: A Randomized Placebo-Controlled Trial
- (2014) Marie Juul Ornstrup et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Effect of Resveratrol Administration on Metabolic Syndrome, Insulin Sensitivity, and Insulin Secretion
- (2014) Miriam Méndez-del Villar et al. Metabolic Syndrome and Related Disorders
- Effects of resveratrol supplementation on plasma lipids: a systematic review and meta-analysis of randomized controlled trials
- (2013) Amirhossein Sahebkar NUTRITION REVIEWS
- The Acute Effects of Grape Polyphenols Supplementation on Endothelial Function in Adults: Meta-Analyses of Controlled Trials
- (2013) Shao-Hua Li et al. PLoS One
- Metabolic syndrome as a predictor of type 2 diabetes, and its clinical interpretations and usefulness
- (2013) Jeong-Ah Shin et al. Journal of Diabetes Investigation
- Hyperlipidemia as a Risk Factor for Cardiovascular Disease
- (2012) Robert H. Nelson PRIMARY CARE
- Clinical trials of resveratrol
- (2011) Ketan R. Patel et al. Annals of the New York Academy of Sciences
- Non-alcoholic fatty liver disease
- (2011) Briohny W. Smith et al. CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES
- GRADE guidelines: 7. Rating the quality of evidence—inconsistency
- (2011) Gordon H. Guyatt et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- GRADE guidelines: 8. Rating the quality of evidence—indirectness
- (2011) Gordon H. Guyatt et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- GRADE guidelines: 4. Rating the quality of evidence—study limitations (risk of bias)
- (2011) Gordon H. Guyatt et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- GRADE guidelines 6. Rating the quality of evidence—imprecision
- (2011) Gordon H. Guyatt et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- What Is New for an Old Molecule? Systematic Review and Recommendations on the Use of Resveratrol
- (2011) Ole Vang et al. PLoS One
- Insulin Resistance in Nonalcoholic Fatty Liver Disease
- (2010) E. Bugianesi et al. CURRENT PHARMACEUTICAL DESIGN
- Fatty liver: Role of inflammation and fatty acid nutrition
- (2010) Christopher D Byrne PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS
- Hepatic insulin resistance, metabolic syndrome and cardiovascular disease
- (2009) Reza Meshkani et al. CLINICAL BIOCHEMISTRY
- Oxidative stress and metabolic syndrome
- (2009) Christian K. Roberts et al. LIFE SCIENCES
- GRADE: an emerging consensus on rating quality of evidence and strength of recommendations
- (2008) Gordon H Guyatt et al. BMJ-British Medical Journal
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started